Charles River Laboratories International Inc (NYSE:CRL)
$ 219.4 -0.30 (-0.14%) Market Cap: 10.57 Bil Enterprise Value: 13.48 Bil PE Ratio: 0 PB Ratio: 3.59 GF Score: 70/100

Charles River Laboratories International Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2026 / 06:30PM GMT
Release Date Price: $218.99 (+0.08%)
Casey Woodring
JPMorgan Chase & Co - Analyst

Hi, everybody. Welcome to the JPMorgan Healthcare Conference. I'm Casey Woodring from the Life Science Tools and Diagnostics team. Pleased to be joined by Charles River Labs CEO, Jim Foster. Jim is going to give the corporate presentation, and then we'll jump right into Q&A afterwards.

Jim, the floor is yours.

James C. Foster
Charles River Laboratories International Inc - Chair, President, Chief Executive Officer

Thanks so much. Pleasure to be here, as always. Our safe harbor, Reg G and quiet period disclaimers. So we are a nonclinical CRO working with clients from early discovery all the way through manufacture of their drugs. We've got 20,000 employees right now and 2,500 with advanced degrees.

70% of our revenue comes from pharmaceutical industry. We've actually reduced the number of locations that we have, but we still have 120. So we're pretty spread out in most relevant geographies. We have the number one share position in most -- in many of our businesses, particularly research

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot